Ribon Therapeutics

Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic
Fierce Biotech
Wed, 07/14/21 - 10:35 am
Ribon Therapeutics
funding
PARP7 inhibitors
Ribon hires CMO as lead PARP drug nears clinical trials
Fierce Biotech
Tue, 08/6/19 - 10:57 am
Ribon Therapeutics
CMO
Parasuraman
Ribon Therapeutics Raises $65 Million to Advance Novel Cancer Pipeline
CP Wire
Fri, 01/4/19 - 09:18 am
Ribon Therapeutics
Ribon Therapeutics Raises $65 Million to Advance Novel Cancer Pipeline
Fri, 01/4/19 - 09:13 am
Ribon Therapeutics